TABLE A3.
First Author | Clearly Stated Aim | Inclusion of Consecutive Patients | Prospective Data Collection | Endpoints Appropriate to Aim of Study | Unbiased Assessment of Study Endpoint | Follow-up Period Appropriate to Aim of Study | <5% Loss to Follow-up | Prospective Calculation of Sample Size | Adequate Control Group | Contemporary Groups | Baseline Equivalence of Groups | Adequate Statistical Analyses | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ogut61 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 7 | ||||
Dekker12 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Karnovsky35 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 2 | 2 | 16 |
DeSandis13 | 1 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 6 | ||||
Pagliazzi62 | 1 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 7 | ||||
Sadlik74 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 2 | 2 | 18 |
Vuurberg96 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Ogilvie-Harris58 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Bonnin6 | 1 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 7 | ||||
Kumai43 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 4 | ||||
Ogilvie-Harris59 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 4 | ||||
Ogilvie-Harris60 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Draper17 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 2 | 14 |
Savva75 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Ferkel20 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Ventura94 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Dunlap18 | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
van Bergen88 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Kramer41 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Lee47 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Reilingh69 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 22 |
van Eekeren92 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Kumai44 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 4 | ||||
Schuh77 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Kim38 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Sun85 | 1 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 9 | ||||
Guney26 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Hankemeier29 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Murphy54 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 12 | ||||
Saxena76 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 12 | ||||
Domayer15 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 7 | ||||
Rosenberger72 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 3 | ||||
Lee46 | 2 | 1 | 0 | 2 | 0 | 2 | 0 | 0 | 7 | ||||
Haasper27 | 2 | 2 | 0 | 2 | 0 | 1 | 0 | 0 | 7 | ||||
Valderrabano86 | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Hangody28 | 0 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Kennedy36 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 3 | ||||
Paul63 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Pearce64 | 0 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Hu32 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Leumann48 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Petersen65 | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 9 | ||||
Ahmad1 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 2 | 2 | 18 |
Fraser21 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Hintermann31 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Zhu98 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Kim39 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Gautier22 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 4 | ||||
Baums4 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Giannini23 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Giannini24 | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Aurich3 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 0 | 12 | ||||
Magnan51 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 6 | ||||
Coetzee9 | 2 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 5 | ||||
Nehrer55 | 1 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 9 | ||||
Valderrabano87 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Kubosch42 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 | ||||
Gottschalk25 | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 10 | ||||
Clanton8 | 0 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 6 | ||||
Richter71 | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 9 | ||||
Ettinger19 | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 8 |
aMINORS, Methodological Index for Non-Randomized Studies.